Mercado global de glicosímetros – Tendências do setor e previsão para 2030

Análise e dimensão do mercado de glicómetros:

A crescente prevalência da diabetes é um dos principais fatores que impulsionam o crescimento do mercado dos glicosímetros. A crescente consciencialização sobre a gestão da diabetes e o aumento dos gastos em infraestruturas de saúde aceleram o crescimento do mercado dos glicosímetros.

A Data Bridge Market Research analisa que o mercado global de glicosímetros, que foi de 15,80 mil milhões de dólares em 2022, dispararia para 17,03 mil milhões de dólares até 2030 e deverá passar por um CAGR de 9,9% durante o período de previsão. O segmento de dispositivos de monitorização contínua de glicose domina o segmento de produtos do mercado de glicosímetros devido aos avanços na tecnologia que levaram ao desenvolvimento de avanços em medicamentos para diversas utilizações.

Além dos insights sobre cenários de mercado, tais como valor de mercado, taxa de crescimento, segmentação, cobertura geográfica e grandes players, os relatórios de mercado com curadoria da Data Bridge Market Research incluem também análise especializada aprofundada, epidemiologia de pacientes, análise de pipeline, análise de preços, e quadro regulamentar.

Âmbito e segmentação do mercado de glicosímetros

Market Definition

Glucometers work by analyzing a small sample of blood obtained from a finger prick or other suitable site. The device measures the amount of glucose in the blood, displayed on a digital screen. This information helps individuals with diabetes manage their condition by allowing them to monitor their blood sugar levels and make informed decisions regarding their diet, exercise, and medication.

Global Glucometer Market Dynamics

Drivers

• Rising Prevalence of Diabetes:

The increasing prevalence of diabetes worldwide is a significant driver for the glucometer market. Diabetes is a chronic disease that requires regular monitoring of blood glucose levels, and glucometers provide a convenient and effective means of doing so

• Growing Aging Population:

The global aging population is rising, and older individuals are more susceptible to developing diabetes. As the elderly population grows, the demand for glucometers increases, as they are essential for managing diabetes in older adults.

• Technological Advancements:

Continuous advancements in glucometer technology have expanded the market by introducing more accurate, user-friendly, and convenient devices. Features like wireless connectivity, smartphone integration, and compact designs have made glucometers more appealing to users.

Opportunities

• Increasing Awareness and Education:

The growing awareness about diabetes and its management has increased the glucometer demand. Educational campaigns, initiatives by healthcare organizations, and patient education programs have helped raise awareness about the importance of regular blood glucose monitoring.

• Government Initiatives:

Governments and healthcare organizations worldwide have recognized the significance of managing diabetes and its complications. They have implemented initiatives to promote diabetes screening, monitoring, and management, which have fueled the demand for glucometers.

Restraints

• Regulatory Challenges:

Glucometers are medical devices, and their manufacturing, distribution, and usage are subject to various regulations and standards imposed by regulatory bodies such as the Food and Drug Administration (FDA) in the United States. Compliance with these regulations can be time-consuming and expensive, and any changes or updates in the regulatory landscape can pose challenges to glucometer manufacturers.

Challenges

• Alternative Monitoring Methods

While glucometers are widely used for blood glucose monitoring, alternative methods such as continuous glucose monitoring (CGM) systems have gained popularity. CGM systems provide real-time glucose readings and eliminate the need for frequent finger pricking. The availability and adoption of alternative monitoring methods could impact the demand for traditional glucometers.

This global glucometer market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global glucometer market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Development

• In July 2023, Thermo Fisher Scientific would acquire healthcare data provider CorEvitas for USD 912.5 million in cash as the medical products maker looks to boost its portfolio of services offered to pharmaceutical clients.
• In June 2023, B.D., a leading global medical technology company, announced that it had signed a definitive agreement to sell its Surgical Instrumentation platform to STERIS (NYSE: STE) for USD 540 million.

Global Glucometer Market Scope

The global glucometer market is segmented on the basis of product, technique, type, and distribution channel. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

• Continuous Glucose Monitoring Devices
• Self-Monitoring Blood Glucose (SMBG) Systems

Technique

• Invasive
• Non-Invasive

Type

• Wearable
• Non-Wearable

Distribution channel

• Institutional Sales
• Hospitals
• Clinics
• Retail Sales
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies.
• Others

Global Glucometer Market regional analysis/insights

The global glucometer market is analysed and market size insights and trends are the basis product, technique, type, and distribution channel as referenced above.

The countries covered in the Global Glucometer Market report are U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, Saudi Arabia, U.A.E, South Africa, Egypt, Israel, rest of Middle East and Africa, Brazil, Argentina and rest of South America.

North America is expected to grow to dominate the market due to major key players, high disposable income, high healthcare expenditure, and a well-developed healthcare sector in this region.

Asia-Pacific is expected to grow during the forecast period of 2023-2030 due to the increasing research and development activities, rising investment in the healthcare sector, and growing government support.

A secção do país do relatório também fornece fatores individuais de impacto no mercado e alterações na regulamentação do mercado interno que impactam as tendências atuais e futuras do mercado. Pontos de dados como a análise da cadeia de valor a jusante e a montante, tendências técnicas e análise das cinco forças de Porter, estudos de caso são alguns dos indicadores utilizados para prever o cenário de mercado para países individuais. Além disso, são considerados a presença e disponibilidade de marcas globais e os desafios enfrentados devido à grande ou escassa concorrência de marcas locais e nacionais, o impacto das tarifas nacionais e das rotas comerciais, ao mesmo tempo que se fornece uma análise de previsão dos dados do país.   

Base instalada de crescimento da infraestrutura de saúde e penetração de novas tecnologias

O mercado global de glicosímetros também fornece análises de mercado detalhadas para o crescimento de cada país em termos de despesas de saúde para equipamentos de capital, base instalada de diferentes tipos de produtos para o mercado global de glicosímetros, impacto da tecnologia utilizando curvas de linha de vida e alterações nos cenários regulamentares de saúde e o seu impacto no mercado global de glucómetros. Os dados estão disponíveis para o período histórico 2015-2020.

Cenário competitivo e análise global da quota de mercado de glicómetros

O panorama competitivo do mercado global de glicosímetros fornece detalhes por concorrente. Os detalhes incluídos são a visão geral da empresa, finanças da empresa, receitas geradas, potencial de mercado, investimento em investigação e desenvolvimento, novas iniciativas de mercado, presença global, localizações e instalações de produção, capacidades de produção, pontos fortes e fracos da empresa , lançamento de produto, largura e amplitude do produto, aplicação domínio. Os dados acima fornecidos estão apenas relacionados com o foco das empresas em relação ao mercado.

Alguns dos principais players que trabalham no mercado global de glicosímetros são:

• Thermo Fisher Scientific, Inc.
• Promega Corporation (EUA)
• (EUA)
• (EUA)
• QIAGEN (Alemanha)
• Merck KGaA (Alemanha)
• BD (EUA)
• Sanofi (França)
• Ascensia Diabetes Care Holdings AG (EUA)
• Abbott (EUA)
• (EUA)
• F. Hoffmann-La Roche Ltd (Suíça)
• (EUA)
• Bayer AG (Alemanha)
• Medtronic (Irlanda)
• (EUA)
• (Japão) 
• (EUA)
• Trividia Health, Inc.
• Medisana GmbH (Alemanha) 

SKU-13164